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Abstract
Volatile nitrosamines (VNAs) are a group of compounds classified as probable (group 2A) and 
possible (group 2B) carcinogens in humans. Along with certain foods and contaminated drinking 
water, VNAs are detected at high levels in tobacco products and in both mainstream and 
sidestream smoke. Our laboratory monitors six urinary VNAs—N-nitrosodimethylamine 
(NDMA), N-nitrosomethylethylamine (NMEA), N-nitrosodiethylamine (NDEA), N-
nitrosopiperidine (NPIP), N-nitrosopyrrolidine (NPYR), and N-nitrosomorpholine (NMOR)—
using isotope dilution GC-MS/MS (QQQ) for large population studies such as the National Health 
and Nutrition Examination Survey (NHANES). In this paper, we report for the first time a new 
automated sample preparation method to more efficiently quantitate these VNAs. Automation is 
done using Hamilton STAR™ and Caliper Staccato™ workstations. This new automated method 
reduces sample preparation time from 4 hours to 2.5 hours while maintaining precision (inter-run 
CV < 10%) and accuracy (85% - 111%). More importantly this method increases sample 
throughput while maintaining a low limit of detection (<10 pg/mL) for all analytes. A streamlined 
sample data flow was created in parallel to the automated method, in which samples can be 
tracked from receiving to final LIMs output with minimal human intervention, further minimizing 
human error in the sample preparation process. This new automated method and the sample data 
flow are currently applied in bio-monitoring of VNAs in the US non-institutionalized population 
NHANES 2013-2014 cycle.
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Volatile nitrosamines (VNAs) are a class of nitrosated secondary and tertiary amines (Figure 
1). VNAs are known carcinogens and teratogens in animals and are classified as group 2A 
and 2B carcinogens in humans [1]-[9]. They have been shown to induce tumors via 
cytochrome-activated DNA alkylation in several organs, including liver, lungs, kidney, 
bladder, pancreas, and esophagus [1] [5]-[7] [9] [10]. VNAs may lead to lipid peroxidation 
and oxidative stress, as well as chronic diseases such as diabetes and Alzheimer’s disease 
[11]-[18].
The formation of volatile nitrosamines occurs through the nitrosation of secondary and 
tertiary amines via interaction with nitrite, which itself is a product of nitrate reduction [3]-
[5] [7] [8] [19] [20]. For this reason, VNAs can be formed from many items containing 
nitrates and nitrites, such as cured meats, fish products, cosmetics, certain types of beers, 
and tobacco products (as part of the curing process and during product assembly), as well as 
in both mainstream and sidestream tobacco smoke [2] [4] [7] [21]-[23]. Another significant 
source of VNA exposure can be drinking water: VNAs, particularly NDMA, can form as 
byproducts during disinfection via chlorination and chloramination [2] [9] [24]-[28].
Many different methods are reported for VNA measurements. For sample preparation, 
dichloromethane is the solvent of choice for extracting VNAs from the sample matrix (e.g. 
water, urine, serum), whether in a direct liquid-liquid extraction or using a solid phase 
intermediary [9] [24]. As for instrumentation, gas chromatography is the most common 
separation technique due to the eponymous volatility of VNAs, though some labs have 
developed various liquid chromatography methods [2] [5] [6] [22] [23] [27]. Detection 
methods range from single- and triple-quadrupole mass spectrometry to thermal energy 
analysis and nitrogen chemiluminescence detection, though mass spectrometry is the most 
commonly used [1] [8] [19] [20] [25] [26] [28].
Automation is necessary for higher sample throughput in large population studies such as 
NHANES, whose sample size is approximately 10,000 per two-year cycle. In this study, we 
present an automated method utilizing both Caliper Staccato and Hamilton Star 
workstations. The throughput is increased by automation equipment, and the sensitivity is 
increased due in part to an upgrade of the QQQ from an Agilent 7000B to a 7000C. We 
created a streamlined sample data flow in parallel to the automated method, in which 
samples can be tracked from receiving to final LIMs output with minimal human 
intervention, further minimizing human error in the sample preparation process.
2. Methods and Materials
2.1. Materials
Native standards were purchased from Supelco (Sigma-Aldrich, St. Louis, MO) as a 2 
mg/mL mixture in dichloromethane (DCM). Deuterium-labeled internal standards NDMA-
D6, NDEA-D10, NPYR-D8, and NMOR-D8 were purchased individually in DCM from 
Cambridge Isotope Laboratories (Tewksbury, MA); NMEA-D3 and NPIP-D10 were 
purchased individually as pure oils from Toronto Research Chemicals (Toronto, Canada). 
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Methanol (MeOH), DCM, and acetonitrile (ACN) were HPLC grade, purchased from 
Honeywell Burdick & Jackson (Muskegon, MI). Sample plates were Axygen 48-well plates 
with a 5 mL well capacity. GC vials were Wheaton 11 mm amber crimp vials with a 300 μL 
insert; crimp caps were SUN-SRi 11 mm aluminum crimp caps with rubber septum. All GC-
QQQ parts were purchased from Agilent Technologies (Santa Clara, CA).
2.2. Hamilton Microlab Star Liquid Handling Workstation
All sample and internal standard aliquoting was performed on the Hamilton Microlab Star 
liquid handling workstation. The pipetting array consisted of 8 pipetting heads and used 
1000 μL and 50 μL compressed O-ring expansion (CO-RE) tips. All samples were aspirated 
using capacitance liquid level detection (cLLD) and dispensed using the jet empty setting. 
Samples were mixed (consisting of an aspirate of 500 μL and dispense into the same 
container) 3 times prior to being transferred to the sample plate to ensure sample uniformity.
2.3. Caliper Staccato Specimen Handling Workstation
Sample preparation was performed on the Caliper Staccato specimen handling workstation, 
including an integrated Perkin Elmer SciClone G3 Automated Liquid Handling Workstation 
(Figure 2). This system was custom designed with all specimen preparation needs in mind. 
The Staccato station includes the SciClone G3 Workstation, a Biotage TurboVap 96 
Automated Evaporation System, a Hettich GmbH & Co. KG Rotanta 460 Robotic 
Centrifuge, two HyperStak39 consumable loaders, a Thermo Scientific ALPS 3000 sealer, 
and a Mitsubishi S Series Melfa RV-6SDL Industrial Robot.
2.4. Automated Sample Preparation
Urine samples were transferred from cryovials in 2 mL aliquots, along with 500 pg of 
internal standard (in methanol solution, 10 pg/μL), into a 48-well plate using a Hamilton 
Star liquid handling system. The delivered volume of 50 μL was verified gravimetrically 
with % error of less than 1%. The sample plate was transferred to a SciClone liquid handler 
on the Caliper Staccato specimen handling workstation, where 2.5 mL of DCM were added 
to each well. All samples underwent pipette mixing for approximately 40 minutes using the 
96-head main array and 200 μL pipette tips. The plate was sealed using a Thermo Scientific 
ALPS 3000 sealer and centrifuged for 5 minutes (1500 rpm, 25°C) in a Hettich Rotanta 460 
Robotic centrifuge. The sample plate was then moved back onto the SciClone deck, where 
the seal was pierced, and 1.5 mL of the DCM layer in each well were transferred to a new 
48-well plate. Samples were evaporated to approximately 300 μL in a Biotage 96-array 
TurboVap, and the plate was sealed and transferred off the Caliper Staccato system. Each 
sample was then manually transferred via pipette to a 1 mL amber GC vial with a 300 μL 
insert and further evaporated to approximately 100 μL in a ThermoFisher Savant SPD2010 
Speedvac Concentrator. To each sample 50 μL of ACN were added, then the remaining 
DCM was evaporated in the Savant. Sample vials were sealed using aluminum crimp caps 
and transferred to GC-MS/MS (QQQ) for analysis (Figure S1).
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2.5. GC-MS/MS (QQQ) Analysis
All analyses were performed on an Agilent 7890-7000C GC-MS/MS (QQQ). The 7890 GC 
was equipped with a multimode inlet (MMI) and a single taper helix liner. The injection 
volume was 5 μL. The initial injection temperature was 5°C, which was held for 0.85 
minutes after injection and then heated at 600°C/min to 300°C. A programmed temperature 
vaporation (PTV) solvent vent mode was used, venting at 200 mL/min flow rate and 5 psi 
pressure for 0.7 minutes after injection. A two-column setup connected by a backflush union 
was used for the GC, with helium as the carrier gas. The first column was an Agilent DB-
WAXetr (30 m × 0.25 mm × 0.5 μm) with a constant flow rate of 3 mL/min for the first 1.3 
minutes, followed by a 1.2 mL/min flow rate for the remainder of the run. The second 
column was deactivated fused silica (1 m × 0.15 μm) with a constant pressure of 1 psi. The 
GC oven was initially set to 35°C for 1 minute after injection then heated to 245°C at 20°C/
min. A backflush was performed for 5 minutes post-run, with a −1.9795 mL/min constant 
flow for the first column, a 25 psi constant pressure for the second column, and an oven 
temperature of 250°C. The transfer line temperature and MS source were both set to 250°C. 
The 7000C MS source mode was positive chemical ionization (CI) with ammonia (blue 
grade) as the CI gas; ultra-high purity nitrogen was used as the collision gas.
2.6. Sample Data Flow
A mostly automated system for tracking sample data was created in parallel with the 
automated sample preparation method (Figure 3). Samples are received and logged into the 
LIMs reporting system before they are queued for preparation and analysis. Samples to be 
prepared are scanned by the Hamilton Star, which upon completion generates an output file 
mapping scanned samples to positions in the 48-well plate. This Hamilton output file is run 
through an Excel macro which modifies the format so that it can be imported into 
MassHunter as a sequence file. Once the raw data are acquired from the GC-QQQ, they can 
either be analyzed in MassHunter Quantitative software or uploaded to Indigo Biosystems 
ASCENT platform for automatic integration. Regardless of which quantitation software is 
used, a formatted output file containing the final calculated data is generated and can be 
directly uploaded to the LIMs system. Using a custom LIMs system, unknown samples are 
evaluated individually according to a list of QA rules, including retention times of internal 
standard and main ion transition peaks, confirmation ion ratio, internal standard peak area, 
and blank limit. Batch QCs are evaluated according to modified Westgard QC rules [29]. 
Final results are then exported to a final reporting system such as NHANES.
3. Results
3.1. Blanks
A true blank has proven difficult to produce, as VNAs—particularly NDMA—are detected 
in all water sources tested thus far, including Fluka Analytical TraceSELECT ultratrace 
water (Sigma-Aldrich), a commercial source of VOC-free water, and in-house filtered 
“VOC-free” water. NDMA contamination has also been detected when DCM (the extraction 
solvent) comes into contact with any plastic consumable used during the sample preparation 
process, such as the 48-well plates and pipette tips. As a result, DCM is processed as an 
unknown sample and used as the system blank and for blank subtraction. The concentration 
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of NDMA contamination seen in DCM blank samples is approximately 1 - 2 times the LOD 
reported here. The first and last well in the plate contain DCM, spiked with 500 pg ISTD, 
and carried all the way through the sample preparation process. The average calculated 
concentration derived from the analytical results of these two DCM blanks is then subtracted 
from all analytical results for the remainder of that batch (i.e. all other samples prepared in 
the same 48-well plate). The blank subtraction is built into the process of data loading to 
LIMs. Blank characterization was established over 60 separate runs over a one year period. 
Runs are rejected if any DCM blank result exceeds the established blank limits for each 
analyte.
3.2. Carryover
Acetonitrile blanks were run immediately after high (200 pg/mL) QC samples. These blanks 
were then compared with blanks run without any immediately preceding sample. Calculated 
concentrations of the two sets of blanks were within 5% both of one another and of the blank 
characterization values, indicating no carryover. Some small carryover was observed for 
NDMA, NMEA, and NDEA after the injections of the highest standard, 400 ng/mL. After 3 
ACN solvent blank injections, there is no carryover observed for these three analytes. Thus, 
ACN solvent blank is injected three times after the highest standard in every analytical 
batch. As a precaution, a QA rule is built into the LIMs system to flag a sample immediately 
following a high concentration sample (>200 pg/mL). The flagged samples are reinjected to 
ensure no carryover occurred. Carryover is determined by established repeatability criteria: 
20% for lower concentration (<50 pg/mL) and 10% for higher concentration (≥50 pg/mL). If 
a reinjected sample fails repeatability rules, it will be repeated. An ACN blank is also 
injected at the beginning of each analytical batch to ensure no system contamination exists 
prior to sample analysis.
3.3. Limits of Detection (LOD)
The limit of detection for each analyte was obtained from 60 independent runs (limited to 
only 1 run per day) using DCM blanks (carried through sample preparation process, as 
mentioned above), as well as prepared samples from 4 pools: 0 pg/mL, 2.5 pg/mL, 5.0 
pg/mL, and 7.5 pg/mL. Because NDMA, NMEA, NDEA, NPIP, and NMOR have positive 
blank detections, these LODs were calculated using the 3S0 method, where S0 is the 
extrapolated standard deviation at zero concentration. For NPYR, the LOD was determined 
according to the guideline for determination of limits of detection by the Clinical and 
Laboratory Standard Institute using the 4 QC pools [29]. The LODs for all analytes are 
below 10 pg/mL, with three of the analytes (NMEA, NDEA, and NPIP) at or below 5 pg/mL 
(Table 1).
3.4. Precision
To determine intra-run and inter-run precision, in-house anonymous non-smoker urine 
(collected with CDC Institutional Review Board (IRB) approval) was spiked to make two 
QC pools at 50 pg/mL and 200 pg/mL. Six samples of each QC were run for five 
consecutive days. For the 50 pg/mL QC, only one analyte in one run has an intra-run CV 
greater than 10%; the rest of the pool is below 7% CV. For the 200 pg/mL QC, all analytes 
are at or below 5% intra-run CV. For both sets, all inter-run CVs are 5-10% (Table 2).
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3.5. Accuracy in Solution
To determine accuracy of the calibration curve, individual stocks of native NDMA, NDEA, 
NPYR, and NMOR were obtained from a different vendor, Cambridge Isotope Laboratories. 
Because no manufacturer readily carries individual stocks of native NMEA or NPIP, a 
different lot of the Supelco native VNA mixture was obtained. Three levels of calibrator (at 
0.5%, 25%, and 50% of the highest calibrator) were made and run in triplicate for each 
individual stock, as well as for the new mixture. For all three levels, the accuracy is greater 
than 94% for all analytes, both individually and in the mixture (Table 3). This test is 
repeated every time a new standard curve is prepared for analysis.
3.6. Accuracy in Matrix
To determine accuracy in matrix, freshly collected in-house anonymous non-smoker urine 
(collected with CDC Institutional Review Board (IRB) approval) was spiked at 3 different 
levels each day: 100 pg/mL, 200 pg/mL, and 300 pg/mL. These pools were prepared and run 
in triplicate for three consecutive days. For the 100 pg/mL spiked samples, the calculated 
accuracy for all analytes is 85% - 111%; for 200 pg/mL and 300 pg/mL, the accuracy for all 
analytes is 92% - 106% (Table 4).
4. Discussion
Automation of sample preparation processes is a crucial part of bio-monitoring large 
population studies like NHANES. Analyzing more than 10,000 samples per two-year cycle 
requires a much higher throughput than an analyst could perform manually. Our new 
automated method for preparing samples enables the analyst to achieve the necessary 
sample throughput while still maintaining high accuracy and precision. With detection limits 
for all analytes below 10 pg/mL, and three of six at or below 5 pg/mL, these LODs are 
comparable to the ones reported in Seyler, et al. [21]. Also, the staff time saved because of 
the automated steps can be re-allocated to instrument operation and data analysis, further 
increasing throughput.
The automated sample data flow further minimizes human error in sample handling. Sample 
IDs are first tracked during initial sample aliquoting on the Hamilton Star, where an output 
file automatically maps samples to well locations on the 48-well plate. The Hamilton output 
file is then converted to an imported GC-QQQ sequence file via an Excel macro. All 
relevant sample information, such as the sample ID, sample volume, and any dilution 
factors, is saved with each raw data file as the samples are analyzed on the GC-QQQ. The 
current method allows for one of two data analysis processes to occur. Currently, all sample 
data is analyzed using MassHunter Quantitative Analysis software. The ability to manually 
integrate peaks from baseline to baseline makes this method the most accurate for samples at 
low levels, especially around the LODs. The second data analysis process, Indigo 
Biosystems ASCENT platform, is a more automated process but is still being optimized. 
The peak fitting and peak picking algorithms utilized on this platform work well for higher 
concentration samples. The one main impediment to using this platform thus far is the 
inability to adjust peak baselines; the software only allows for two data points to be chosen 
on the chromatogram, and the area between is automatically integrated. This has been of 
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greatest concern in samples around the LODs of all analytes: the algorithm for determining 
the chromatogram baseline creates an undulating baseline, which when picking a small peak 
can artificially increase or decrease the calculated concentration. Indigo is currently 
addressing this problem for this method, and if it can be resolved, then the Indigo ASCENT 
platform will be implemented in the main data analysis process.
5. Conclusion
Overall, the newly automated process is time efficient and precise. At least two batches of 
48 samples can be prepared each day when higher sample throughput is needed. Automation 
has improved the overall accuracy and precision. The new sample data flow has improved 
sample tracking and data analysis, including sample and run quality control evaluation. The 
sample data flow also enables multiple team members to participate and track sample 
analysis progress. The entire sample data flow from sample receiving to final result 
reporting is more efficient while minimizing human errors. This method will be 
implemented to monitor volatile nitrosamines in population studies such as NHANES.
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Structures of volatile nitrosamines.
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Schematic for Caliper Staccato workstation.
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Sample data flow chart.
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Table 1
Limits of detection of all analytes (LODs were obtained from 60 independent runs, limited to one run per day).








Determined by 3S0, where S0 is the standard deviation of blank characterization;
**
Calculated according to CLSI, using 4 pools (0 pg/mL, 2.5 pg/mL, 5.0 pg/mL, 7.5 pg/mL).

















NDMA NMEA NDEA NPIP NPYR NMOR
Intra-run (n = 6)
CV (%)
4.26 4.87 4.63 1.90 4.65 4.69
5.26 2.03 3.60 4.51 6.43 2.43
3.77 2.42 2.68 1.05 6.54 2.18
2.03 2.68 1.93 2.19 3.19 3.16
11.1 3.02 5.16 5.04 5.44 2.54
Inter-run (n = 5) 7.94 6.14 5.17 5.36 9.34 5.16
Pool 2—200 pg/mL
NDMA NMEA NDEA NPIP NPYR NMOR
Intra-run (n = 6)
CV (%)
3.40 2.24 2.68 1.97 2.68 5.07
1.58 1.26 1.69 2.19 2.08 1.24
1.69 2.91 2.33 2.67 2.75 2.49
1.49 2.16 2.76 2.98 2.29 2.20
3.97 3.27 3.55 3.23 4.16 3.32
Inter-run (n = 5) 7.44 7.09 6.78 6.95 5.70 6.12

















n = 3 NDMA NMEA NDEA NPIP NPYR NMOR
Mixed—2 ng/mL 99.9 95.5 95.4 94.8 96.2 94.2
Mixed—100 ng/mL 100 101 100 101 98.7 102
Mixed—200 ng/mL 101 103 101 100 98.7 102
Individual—2 ng/mL 95.7 94.7 96.7 98.0
Individual—100 ng/mL 94.3 99.1 96.8 104
Individual—200 ng/mL 96.7 101 98.8 104
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Table 4
Accuracy in matrix.
100 pg/mL 200 pg/mL 300 pg/mL
n = 9 AVG (%) CV (%) n = 9 AVG (%) CV (%) n = 9 AVG (%) CV (%)
NDMA 85.4 2.56 NDMA 94.0 4.68 NDMA 94.3 4.67
NMEA 95.5 3.94 NMEA 104 5.18 NMEA 102 5.32
NDEA 90.0 3.29 NDEA 97.4 5.16 NDEA 97.3 4.63
NPIP 86.6 4.37 NPIP 92.8 4.88 NPIP 91.9 4.35
NPYR 111 6.80 NPYR 106 5.03 NPYR 100 4.55
NMOR 89.8 3.41 NMOR 95.6 4.43 NMOR 95.7 4.64
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